IA
ONCE

IPL Advisers’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

IPL Advisers’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$7.38M Hold
143,500
– – 4.67% 10
2017
Q3 		$12.8M Buy
143,500
+62,500
+77% +$4.75M 5.24% 10
2017
Q2 		$4.84M Buy
+81,000
New +$4.53M 1.91% 15

Other funds holding ONCE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

IPL Advisers's ONCE Position: Q4 2017 in Review

IPL Advisers held its Spark Therapeutics, Inc. Common Stock (ONCE) position steady in Q4 2017 at 143,500 shares worth $7.38M. The position accounts for 4.67% of the portfolio, ranked #10.

IPL Advisers first reported a position in ONCE in Q2 2017 and has held it in 3 quarters since. The position peaked at $12.8M in Q3 2017. 160 funds tracked by Wall St. Rank hold ONCE as of Q4 2017.

  • IPL Advisers held 143,500 shares of Spark Therapeutics, Inc. Common Stock worth $7.38M as of Q4 2017.
  • IPL Advisers left its Spark Therapeutics, Inc. Common Stock share count unchanged in Q4 2017.
  • Spark Therapeutics, Inc. Common Stock made up 4.67% of IPL Advisers's portfolio in Q4 2017, its #10 holding.
  • IPL Advisers first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2017 and has held it in 3 quarters since.
  • IPL Advisers's Spark Therapeutics, Inc. Common Stock position peaked at $12.8M in Q3 2017.
  • 160 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2017.

Based on IPL Advisers's 13F filing for Q4 2017, filed 14 Feb 2018.